Phase II DESTINY-CRC01: Trastuzumab Deruxtecan in Patients With HER2-Expressing Metastatic Colorectal Cancer

May 29-31, 2020; Online at meetings.asco.org/am
In patients with previously treated HER2+ metastatic CRC, T-DXd associated with a response rate of 45% and durable responses.
Format: Microsoft PowerPoint (.ppt)
File Size: 256 KB
Released: June 1, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Daiichi Sankyo, Inc.

Related Content

In this slideset from Clinical Care Options (CCO), experts provide insights on the optimal use of checkpoint inhibitors for gastroesophageal cancers

Manish A. Shah, MD Zev A. Wainberg, MD Released: August 10, 2020

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on immunotherapy for gastroesophageal cancers

Manish A. Shah, MD Zev A. Wainberg, MD Released: August 10, 2020

In this slideset from Clinical Care Options (CCO), experts discuss new data on gastrointestinal (GI) cancers from ASCO 2020

Axel Grothey Headshot Axel Grothey, MD Manish A. Shah, MD Released: August 7, 2020

From Clinical Care Options (CCO), Axel Grothey, MD, and Manish A. Shah, MD, discuss new data on gastrointestinal (GI) cancers from ASCO 2020

Axel Grothey Headshot Axel Grothey, MD Manish A. Shah, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 7, 2020 Expired: August 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?